Authorized purpose: Samsung V8 is a general diagnostic ultrasound system for broad hospital, clinic, and practice applications; K211945 adds thoracic scanning, AI-based NerveTrack, and AI-based UterineAssist for uterine detection and measurements.
Clinical role
General ultrasound acquisition and analysis with release-specific AI-assisted nerve and uterine workflows.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: The proposed device V8 Ultrasound System did not require clinical studies to demonstrate substantial equivalence.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Samsung V8 is a general diagnostic ultrasound system for broad hospital, clinic, and practice applications; K211945 adds thoracic scanning, AI-based NerveTrack, and AI-based UterineAssist for uterine detection and measurements.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound data obtained by the V8 diagnostic ultrasound system and probes, with 2D, Doppler, ElastoScan, combined, multi-image, and 3D/4D modes.
Who uses it?Intended users: Appropriately trained healthcare professionals operating under qualified clinical supervision.
What does the software produce?Output: Displayed ultrasound data, measurements of anatomical structures, analysis packages, and uterine parameters detected, measured, and calculated by UterineAssist.
What is its most important limitation?Key limitation: The proposed device V8 Ultrasound System did not require clinical studies to demonstrate substantial equivalence.
Clinical takeaway. Clinical role: Samsung V8 is a general diagnostic ultrasound system for broad hospital, clinic, and practice applications; K211945 adds thoracic scanning, AI-based NerveTrack, and AI-based UterineAssist for uterine detection and measurements.
Evidence takeaway. Evidence from the reviewed source record: K211945 reports nonclinical testing of acoustic output, biocompatibility, software, cleaning, electrical, electromagnetic, and mechanical safety. Clinical studies were not required, and no numerical NerveTrack or UterineAssist performance results are public in the summary.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Samsung V8 is a general diagnostic ultrasound system for broad hospital, clinic, and practice applications; K211945 adds thoracic scanning, AI-based NerveTrack, and AI-based UterineAssist for uterine detection and measurements.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Displayed ultrasound data, measurements of anatomical structures, analysis packages, and uterine parameters detected, measured, and calculated by UterineAssist.
Exact FDA submission
Checked 2026-09-19
The exact packet supports displayed data, measurements, analysis packages, and UterineAssist uterine-parameter processing; it does not state NerveTrack visualization as an output.
K211945 reports nonclinical testing of acoustic output, biocompatibility, software, cleaning, electrical, electromagnetic, and mechanical safety. Clinical studies were not required, and no numerical NerveTrack or UterineAssist performance results are public in the summary.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K211945 reports nonclinical testing of acoustic output, biocompatibility, software, cleaning, electrical, electromagnetic, and mechanical safety. Clinical studies were not required, and no numerical NerveTrack or UterineAssist performance results are public in the summary.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K211945 FDA performance package for V8 Diagnostic Ultrasound System
DesignManufacturer nonclinical system, software, probe, acoustic-output, cleaning, and safety verification
PopulationRepresentative broad diagnostic ultrasound applications listed in K211945
Scopeexact submission
Tested versionSamsung V8 release cleared in K211945
IndependenceSponsor or vendor study
K211945
Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound data obtained by the V8 diagnostic ultrasound system and probes, with 2D, Doppler, ElastoScan, combined, multi-image, and 3D/4D modes.
Scope: Exact FDA submission. The exact packet establishes ultrasound data obtained by the system and probes and lists the modes, but does not state the prior live-data wording.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Displayed ultrasound data, measurements of anatomical structures, analysis packages, and uterine parameters detected, measured, and calculated by UterineAssist.
Scope: Exact FDA submission. The exact packet supports displayed data, measurements, analysis packages, and UterineAssist uterine-parameter processing; it does not state NerveTrack visualization as an output.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Displayed ultrasound data, measurements of anatomical structures, analysis packages, and uterine parameters detected, measured, and calculated by UterineAssist.
Scope: Exact FDA submission. The exact packet supports displayed data, measurements, analysis packages, and UterineAssist uterine-parameter processing; it does not state NerveTrack visualization as an output.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Samsung Healthcare USA's security advisories page, published under Boston Imaging (a Samsung company), posts vulnerability impact analyses and patch process statements for Samsung computed tomography, ultrasound and digital radiography modalities (including Log4j, Urgent11, BlueKeep and WannaCry analyses).
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: owning-domain press releases on usa.samsunghealthcare.com state that Boston Imaging is Samsung Medison's U.S. medical imaging business (unified as Samsung HME America, March 2026) and that Samsung Medison is an affiliate of Samsung Electronics. Corporate program statement; exact-release scope is not established.
Only appropriately trained healthcare professionals operating under qualified clinical supervision. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: The FDA summary discloses no clinical study or numerical AI performance results for this release. Current V8 features must be mapped to the installed build and options before use or comparison.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA summary discloses no clinical study or numerical AI performance results for this release. Current V8 features must be mapped to the installed build and options before use or comparison.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: The FDA summary discloses no clinical study or numerical AI performance results for this release. Current V8 features must be mapped to the installed build and options before use or comparison.
exact submission · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
11Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
GE Medical Systems Ultrasound and Primary care Diagnostics
Authorized purpose: Venue, Venue Go, Venue Fit, and Venue Sprint are general-purpose point-of-care ultrasound systems for trained users across broad adult, pediatric, and neonatal applications, with release-specific AI guidance and measurement functions.
GE Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: Vscan Air is a wireless handheld point-of-care ultrasound system for broad adult, pediatric, and neonatal applications. K250087 adds deep-learning automatic bladder-volume measurement and compatibility with separately cleared Caption Guidance and AutoEF functions.
GE Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.
Kosmos acquires, processes, displays, measures, and stores ultrasound with synchronized ECG and digital auscultation across cardiac, lung, abdominal, vascular, musculoskeletal, and interventional applications. Adult-only Auto EF and AI FAST are adjunct functions.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.